Mimedx (MDXG) Net Income towards Common Stockholders Growth (1y) (2012 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -83.41% |
| Sep 30, 2024 | 11.44% |
| Jun 30, 2024 | 134.23% |
| Mar 31, 2024 | 349.89% |
| Dec 31, 2023 | 451.13% |
| Sep 30, 2023 | 170.02% |
| Jun 30, 2023 | 160.20% |
| Mar 31, 2023 | 69.97% |
| Dec 31, 2022 | 681.83% |
| Sep 30, 2022 | -158.01% |
| Jun 30, 2022 | -281.44% |
| Mar 31, 2022 | -22.59% |
| Dec 31, 2021 | 92.26% |
| Sep 30, 2021 | 92.47% |
| Jun 30, 2021 | 61.30% |
| Mar 31, 2021 | -104.31% |
| Dec 31, 2020 | -141.56% |
| Sep 30, 2020 | -519.92% |
| Jun 30, 2020 | 50.81% |
| Mar 31, 2020 | 63.68% |
| Dec 31, 2019 | 79.36% |
| Sep 30, 2019 | 7,054.49% |
| Jun 30, 2019 | -1,053.99% |
| Mar 31, 2019 | -387.36% |
| Dec 31, 2018 | -486.47% |
| Sep 30, 2018 | -101.31% |
| Jun 30, 2018 | -70.35% |
| Mar 31, 2018 | -19.81% |
| Dec 31, 2017 | 253.58% |
| Sep 30, 2017 | 308.70% |
| Jun 30, 2017 | 208.05% |
| Mar 31, 2017 | 381.20% |
| Dec 31, 2016 | -145.62% |
| Sep 30, 2016 | -49.31% |
| Jun 30, 2016 | -63.63% |
| Mar 31, 2016 | -70.71% |
| Dec 31, 2015 | 249.02% |
| Sep 30, 2015 | 77.05% |
| Jun 30, 2015 | 1,492.31% |
| Mar 31, 2015 | 543.28% |
| Dec 31, 2014 | 368.59% |
| Sep 30, 2014 | 1,304.75% |
| Jun 30, 2014 | 48.51% |
| Mar 31, 2014 | 43.10% |
| Dec 31, 2013 | 11.14% |
| Sep 30, 2013 | 92.72% |
| Jun 30, 2013 | -1.79% |
| Mar 31, 2013 | -48.16% |
| Dec 31, 2012 | 37.69% |
| Sep 30, 2012 | -138.96% |
| Jun 30, 2012 | 70.28% |
| Mar 31, 2012 | 67.33% |